Tubular kidney injury molecule‐1 (KIM‐1) in human renal disease
Top Cited Papers
- 11 May 2007
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 212 (2), 209-217
- https://doi.org/10.1002/path.2175
Abstract
KIM-1, a transmembrane tubular protein with unknown function, is undetectable in normal kidneys, but is markedly induced in experimental renal injury. The KIM-1 ectodomain is cleaved, detectable in urine, and reflects renal damage. KIM-1 expression in human renal biopsies and its correlation with urinary KIM-1 (uKIM-1) is unknown. In biopsies from various renal diseases (n = 102) and controls (n = 7), the fraction of KIM-1 positive tubules and different renal damage parameters were scored. Double labelling was performed for KIM-1 with macrophages (MØ), α-smooth muscle actin (α-SMA), proximal (aquaporin-1) and distal (E-cadherin) tubular markers and a dedifferentiation marker (vimentin). uKIM-1 at the time of biopsy (n = 53) was measured by ELISA. Renal KIM-1 was significantly increased in all diseases versus controls (p < 0.05), except minimal change. KIM-1 was primarily expressed at the luminal side of dedifferentiated proximal tubules, in areas with fibrosis (α-SMA) and inflammation (MØ). Independent of the disease, renal KIM-1 correlated positively with renal damage, negatively with renal function, but not with proteinuria. uKIM-1 was increased in renal patients versus controls (p < 0.001), including minimal change, and correlated positively with tissue KIM-1 and MØ, negatively with renal function, but not with proteinuria. In conclusion, KIM-1 is upregulated in renal disease and is associated with renal fibrosis and inflammation. uKIM-1 is also associated with inflammation and renal function, and reflects tissue KIM-1, indicating that it can be used as a non-invasive biomarker in renal disease. Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 26 references indexed in Scilit:
- Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinaseAmerican Journal of Physiology-Renal Physiology, 2007
- ADAM19 expression in human nephrogenesis and renal disease: Associations with clinical and structural deteriorationKidney International, 2006
- Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetesJCI Insight, 2006
- Tubulointerstitial damage and progression of renal failureKidney International, 2005
- Human Kidney Injury Molecule-1 Is a Tissue and Urinary Tumor Marker of Renal Cell CarcinomaJournal of the American Society of Nephrology, 2005
- TIM-4 is the ligand for TIM-1, and the TIM-1–TIM-4 interaction regulates T cell proliferationNature Immunology, 2005
- Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injuryAmerican Journal of Physiology-Renal Physiology, 2004
- Fractalkine expression on human renal tubular epithelial cells: potential role in mononuclear cell adhesionClinical and Experimental Immunology, 2002
- A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndromeKidney International, 2000
- Stage- and segment-specific expression of cell-adhesion molecules N-CAM, A-CAM, and L-CAM in the kidneyKidney International, 1993